Project
Illumina Body Map 2
Navigation
Downloads
Results for AHR_ARNT2
Z-value: 2.42
Motif logo
Transcription factors associated with AHR_ARNT2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
AHR
|
ENSG00000106546.8 | aryl hydrocarbon receptor |
|
ARNT2
|
ENSG00000172379.14 | aryl hydrocarbon receptor nuclear translocator 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ARNT2 | hg19_v2_chr15_+_80696666_80696700 | 0.76 | 4.2e-07 | Click! |
| AHR | hg19_v2_chr7_+_17338239_17338262 | -0.17 | 3.6e-01 | Click! |
Activity profile of AHR_ARNT2 motif
Sorted Z-values of AHR_ARNT2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr22_+_42372931 | 10.24 |
ENST00000328414.8
ENST00000396425.3 |
SEPT3
|
septin 3 |
| chr15_+_84115868 | 10.08 |
ENST00000427482.2
|
SH3GL3
|
SH3-domain GRB2-like 3 |
| chr22_+_42372764 | 9.46 |
ENST00000396426.3
ENST00000406029.1 |
SEPT3
|
septin 3 |
| chr22_+_42372970 | 9.24 |
ENST00000291236.11
|
SEPT3
|
septin 3 |
| chr19_-_18314836 | 8.47 |
ENST00000464076.3
ENST00000222256.4 |
RAB3A
|
RAB3A, member RAS oncogene family |
| chr19_-_18314799 | 8.05 |
ENST00000481914.2
|
RAB3A
|
RAB3A, member RAS oncogene family |
| chr4_-_168155577 | 7.41 |
ENST00000541354.1
ENST00000509854.1 ENST00000512681.1 ENST00000421836.2 ENST00000510741.1 ENST00000510403.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr8_-_9760839 | 7.32 |
ENST00000519461.1
ENST00000517675.1 |
LINC00599
|
long intergenic non-protein coding RNA 599 |
| chr1_+_6845384 | 7.24 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr15_-_79383102 | 6.97 |
ENST00000558480.2
ENST00000419573.3 |
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1 |
| chr15_+_84116106 | 6.97 |
ENST00000535412.1
ENST00000324537.5 |
SH3GL3
|
SH3-domain GRB2-like 3 |
| chr4_-_168155169 | 6.91 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chrX_-_152939252 | 6.87 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr17_-_77179487 | 6.81 |
ENST00000580508.1
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
| chr4_-_168155730 | 6.62 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr10_-_104178857 | 6.52 |
ENST00000020673.5
|
PSD
|
pleckstrin and Sec7 domain containing |
| chr4_-_168155700 | 6.47 |
ENST00000357545.4
ENST00000512648.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr3_+_6902794 | 6.36 |
ENST00000357716.4
ENST00000486284.1 ENST00000389336.4 ENST00000403881.1 ENST00000402647.2 |
GRM7
|
glutamate receptor, metabotropic 7 |
| chrX_-_152939133 | 5.94 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr4_-_168155300 | 5.87 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr4_-_168155417 | 5.67 |
ENST00000511269.1
ENST00000506697.1 ENST00000512042.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr20_-_44937124 | 5.53 |
ENST00000537909.1
|
CDH22
|
cadherin 22, type 2 |
| chr12_+_103351444 | 5.25 |
ENST00000266744.3
|
ASCL1
|
achaete-scute family bHLH transcription factor 1 |
| chr5_+_161494770 | 5.03 |
ENST00000414552.2
ENST00000361925.4 |
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
| chr6_+_108487245 | 4.97 |
ENST00000368986.4
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1 |
| chrX_-_20134990 | 4.94 |
ENST00000379651.3
ENST00000443379.3 ENST00000379643.5 |
MAP7D2
|
MAP7 domain containing 2 |
| chr5_+_161494521 | 4.85 |
ENST00000356592.3
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
| chr3_-_160823158 | 4.82 |
ENST00000392779.2
ENST00000392780.1 ENST00000494173.1 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
| chr19_+_18718214 | 4.81 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
| chr6_-_163834852 | 4.55 |
ENST00000604200.1
|
CAHM
|
colon adenocarcinoma hypermethylated (non-protein coding) |
| chr16_+_6069072 | 4.51 |
ENST00000547605.1
ENST00000550418.1 ENST00000553186.1 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr8_+_85095497 | 4.50 |
ENST00000522455.1
ENST00000521695.1 |
RALYL
|
RALY RNA binding protein-like |
| chr9_+_140033862 | 4.37 |
ENST00000350902.5
ENST00000371550.4 ENST00000371546.4 ENST00000371555.4 ENST00000371553.3 ENST00000371559.4 ENST00000371560.3 |
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
| chr4_+_158142750 | 4.33 |
ENST00000505888.1
ENST00000449365.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr11_+_112832090 | 4.32 |
ENST00000533760.1
|
NCAM1
|
neural cell adhesion molecule 1 |
| chr12_+_119419294 | 4.31 |
ENST00000267260.4
|
SRRM4
|
serine/arginine repetitive matrix 4 |
| chr7_-_44365020 | 4.23 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chrX_-_128788914 | 4.21 |
ENST00000429967.1
ENST00000307484.6 |
APLN
|
apelin |
| chr1_+_110693103 | 4.17 |
ENST00000331565.4
|
SLC6A17
|
solute carrier family 6 (neutral amino acid transporter), member 17 |
| chr12_-_45270077 | 4.14 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
| chr11_+_112832202 | 4.12 |
ENST00000534015.1
|
NCAM1
|
neural cell adhesion molecule 1 |
| chr21_+_41239243 | 4.08 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
| chr3_-_47619623 | 4.07 |
ENST00000456150.1
|
CSPG5
|
chondroitin sulfate proteoglycan 5 (neuroglycan C) |
| chr1_+_77747656 | 4.07 |
ENST00000354567.2
|
AK5
|
adenylate kinase 5 |
| chr12_+_106976678 | 4.07 |
ENST00000392842.1
|
RFX4
|
regulatory factor X, 4 (influences HLA class II expression) |
| chr3_-_160823040 | 4.05 |
ENST00000484127.1
ENST00000492353.1 ENST00000473142.1 ENST00000468268.1 ENST00000460353.1 ENST00000320474.4 ENST00000392781.2 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
| chr11_+_112832133 | 3.96 |
ENST00000524665.1
|
NCAM1
|
neural cell adhesion molecule 1 |
| chr12_-_45270151 | 3.94 |
ENST00000429094.2
|
NELL2
|
NEL-like 2 (chicken) |
| chr6_+_84563295 | 3.90 |
ENST00000369687.1
|
RIPPLY2
|
ripply transcriptional repressor 2 |
| chr7_-_44365216 | 3.86 |
ENST00000358707.3
ENST00000457475.1 ENST00000440254.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr2_+_171673072 | 3.84 |
ENST00000358196.3
ENST00000375272.1 |
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa) |
| chr19_-_56988677 | 3.78 |
ENST00000504904.3
ENST00000292069.6 |
ZNF667
|
zinc finger protein 667 |
| chr10_+_26505594 | 3.71 |
ENST00000259271.3
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
| chr13_-_53422640 | 3.70 |
ENST00000338862.4
ENST00000377942.3 |
PCDH8
|
protocadherin 8 |
| chr12_+_121088291 | 3.68 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
| chr19_+_30719410 | 3.61 |
ENST00000585628.1
ENST00000591488.1 |
ZNF536
|
zinc finger protein 536 |
| chr8_+_26434578 | 3.61 |
ENST00000493789.2
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr4_+_158141806 | 3.55 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr8_+_85095013 | 3.53 |
ENST00000522613.1
|
RALYL
|
RALY RNA binding protein-like |
| chr9_-_131155773 | 3.51 |
ENST00000608502.1
|
MIR219-2
|
microRNA 219-2 |
| chr18_-_35145689 | 3.48 |
ENST00000591287.1
ENST00000601019.1 ENST00000601392.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
| chr1_-_37499726 | 3.47 |
ENST00000373091.3
ENST00000373093.4 |
GRIK3
|
glutamate receptor, ionotropic, kainate 3 |
| chr2_+_219824357 | 3.41 |
ENST00000302625.4
|
CDK5R2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
| chr3_-_160822858 | 3.38 |
ENST00000488170.1
|
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
| chr8_-_132052458 | 3.37 |
ENST00000377928.3
|
ADCY8
|
adenylate cyclase 8 (brain) |
| chr10_-_118885954 | 3.32 |
ENST00000392901.4
|
KIAA1598
|
KIAA1598 |
| chr8_+_85095769 | 3.30 |
ENST00000518566.1
|
RALYL
|
RALY RNA binding protein-like |
| chr21_+_17961006 | 3.29 |
ENST00000602323.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr18_-_35145728 | 3.29 |
ENST00000361795.5
ENST00000603232.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
| chr4_+_4388805 | 3.26 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr1_-_228353112 | 3.22 |
ENST00000366713.1
|
IBA57-AS1
|
IBA57 antisense RNA 1 (head to head) |
| chr12_-_16758835 | 3.16 |
ENST00000541295.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr6_+_73331918 | 3.14 |
ENST00000402622.2
ENST00000355635.3 ENST00000403813.2 ENST00000414165.2 |
KCNQ5
|
potassium voltage-gated channel, KQT-like subfamily, member 5 |
| chr6_+_101847105 | 3.12 |
ENST00000369137.3
ENST00000318991.6 |
GRIK2
|
glutamate receptor, ionotropic, kainate 2 |
| chrX_-_20134713 | 3.10 |
ENST00000452324.3
|
MAP7D2
|
MAP7 domain containing 2 |
| chr11_+_107461804 | 3.09 |
ENST00000531234.1
|
ELMOD1
|
ELMO/CED-12 domain containing 1 |
| chr19_-_2721412 | 3.09 |
ENST00000323469.4
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
| chr12_-_16758873 | 3.08 |
ENST00000535535.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr2_-_170219037 | 3.08 |
ENST00000443831.1
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chrX_+_21392553 | 3.04 |
ENST00000279451.4
|
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr10_-_135150367 | 3.00 |
ENST00000368555.3
ENST00000252939.4 ENST00000368558.1 ENST00000368556.2 |
CALY
|
calcyon neuron-specific vesicular protein |
| chr18_-_35145981 | 2.93 |
ENST00000420428.2
ENST00000412753.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
| chr17_+_43972010 | 2.93 |
ENST00000334239.8
ENST00000446361.3 |
MAPT
|
microtubule-associated protein tau |
| chr11_+_369804 | 2.93 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
| chr9_-_101471479 | 2.91 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
| chr19_-_19006890 | 2.88 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
| chr5_+_176237478 | 2.87 |
ENST00000329542.4
|
UNC5A
|
unc-5 homolog A (C. elegans) |
| chr18_-_35145593 | 2.85 |
ENST00000334919.5
ENST00000591282.1 ENST00000588597.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
| chr22_-_44258360 | 2.82 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr2_-_50201327 | 2.81 |
ENST00000412315.1
|
NRXN1
|
neurexin 1 |
| chr5_-_176057518 | 2.80 |
ENST00000393693.2
|
SNCB
|
synuclein, beta |
| chr10_+_60936347 | 2.79 |
ENST00000373880.4
|
PHYHIPL
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
| chr19_+_55795493 | 2.78 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr1_+_1950763 | 2.77 |
ENST00000378585.4
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta |
| chr19_-_19006920 | 2.77 |
ENST00000429504.2
ENST00000427170.2 |
CERS1
|
ceramide synthase 1 |
| chr8_+_85095553 | 2.73 |
ENST00000521268.1
|
RALYL
|
RALY RNA binding protein-like |
| chr14_+_29236269 | 2.72 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr19_-_46145696 | 2.72 |
ENST00000588172.1
|
EML2
|
echinoderm microtubule associated protein like 2 |
| chr4_+_158141843 | 2.72 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr17_+_30594823 | 2.68 |
ENST00000536287.1
|
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr20_-_3154162 | 2.68 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
| chr10_+_95517660 | 2.68 |
ENST00000371413.3
|
LGI1
|
leucine-rich, glioma inactivated 1 |
| chrX_+_21392529 | 2.67 |
ENST00000425654.2
ENST00000543067.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr18_-_24443151 | 2.67 |
ENST00000440832.3
|
AQP4
|
aquaporin 4 |
| chr9_-_10612703 | 2.66 |
ENST00000463477.1
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D |
| chr12_-_6809543 | 2.66 |
ENST00000540656.1
|
PIANP
|
PILR alpha associated neural protein |
| chr16_+_6069586 | 2.63 |
ENST00000547372.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr3_-_62358690 | 2.62 |
ENST00000475839.1
|
FEZF2
|
FEZ family zinc finger 2 |
| chr5_+_175223313 | 2.62 |
ENST00000359546.4
|
CPLX2
|
complexin 2 |
| chr10_+_83634940 | 2.62 |
ENST00000372141.2
ENST00000404547.1 |
NRG3
|
neuregulin 3 |
| chr5_-_176057365 | 2.61 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
| chr4_+_158141899 | 2.60 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
| chr4_-_6474173 | 2.60 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr7_+_54610086 | 2.59 |
ENST00000404951.1
|
VSTM2A
|
V-set and transmembrane domain containing 2A |
| chr13_+_37247934 | 2.59 |
ENST00000315190.3
|
SERTM1
|
serine-rich and transmembrane domain containing 1 |
| chr8_-_110986918 | 2.56 |
ENST00000297404.1
|
KCNV1
|
potassium channel, subfamily V, member 1 |
| chr1_-_38512450 | 2.56 |
ENST00000373012.2
|
POU3F1
|
POU class 3 homeobox 1 |
| chr2_-_142888573 | 2.55 |
ENST00000434794.1
|
LRP1B
|
low density lipoprotein receptor-related protein 1B |
| chr6_-_84419101 | 2.54 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr16_-_10276611 | 2.54 |
ENST00000396573.2
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
| chr10_+_95517616 | 2.53 |
ENST00000371418.4
|
LGI1
|
leucine-rich, glioma inactivated 1 |
| chr6_+_34433844 | 2.53 |
ENST00000244458.2
ENST00000374043.2 |
PACSIN1
|
protein kinase C and casein kinase substrate in neurons 1 |
| chr18_-_76738843 | 2.51 |
ENST00000575722.1
ENST00000583511.1 |
RP11-849I19.1
|
RP11-849I19.1 |
| chr12_+_110906169 | 2.50 |
ENST00000377673.5
|
FAM216A
|
family with sequence similarity 216, member A |
| chr2_-_213403565 | 2.49 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
| chrX_+_152783131 | 2.49 |
ENST00000349466.2
ENST00000370186.1 |
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3 |
| chr19_+_12949251 | 2.49 |
ENST00000251472.4
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
| chr2_-_119916459 | 2.48 |
ENST00000272520.3
|
C1QL2
|
complement component 1, q subcomponent-like 2 |
| chr2_-_213403253 | 2.46 |
ENST00000260943.6
ENST00000402597.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
| chr19_-_44324750 | 2.46 |
ENST00000594049.1
ENST00000414615.2 |
LYPD5
|
LY6/PLAUR domain containing 5 |
| chrX_+_134555863 | 2.45 |
ENST00000417443.2
|
LINC00086
|
long intergenic non-protein coding RNA 86 |
| chr11_-_35440796 | 2.43 |
ENST00000278379.3
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
| chr20_-_23402028 | 2.39 |
ENST00000398425.3
ENST00000432543.2 ENST00000377026.4 |
NAPB
|
N-ethylmaleimide-sensitive factor attachment protein, beta |
| chr20_+_34680620 | 2.38 |
ENST00000430276.1
ENST00000373950.2 ENST00000452261.1 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr8_-_67090825 | 2.36 |
ENST00000276571.3
|
CRH
|
corticotropin releasing hormone |
| chr1_-_50489547 | 2.36 |
ENST00000371836.1
ENST00000371839.1 ENST00000371838.1 |
AGBL4
|
ATP/GTP binding protein-like 4 |
| chr6_+_99282570 | 2.34 |
ENST00000328345.5
|
POU3F2
|
POU class 3 homeobox 2 |
| chrX_+_129305623 | 2.31 |
ENST00000257017.4
|
RAB33A
|
RAB33A, member RAS oncogene family |
| chr2_-_219433014 | 2.30 |
ENST00000418019.1
ENST00000454775.1 ENST00000338465.5 ENST00000415516.1 ENST00000258399.3 |
USP37
|
ubiquitin specific peptidase 37 |
| chr16_+_776936 | 2.30 |
ENST00000549114.1
ENST00000341413.4 ENST00000562187.1 ENST00000564537.1 |
HAGHL
|
hydroxyacylglutathione hydrolase-like |
| chr13_-_36705425 | 2.27 |
ENST00000255448.4
ENST00000360631.3 ENST00000379892.4 |
DCLK1
|
doublecortin-like kinase 1 |
| chr1_+_204797749 | 2.27 |
ENST00000367172.4
ENST00000367171.4 ENST00000367170.4 ENST00000338515.6 ENST00000339876.6 ENST00000338586.6 ENST00000539706.1 ENST00000360049.4 ENST00000367169.4 ENST00000446412.1 ENST00000403080.1 |
NFASC
|
neurofascin |
| chr20_+_58179582 | 2.27 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
| chr7_+_153749732 | 2.26 |
ENST00000377770.3
|
DPP6
|
dipeptidyl-peptidase 6 |
| chr11_-_18813353 | 2.26 |
ENST00000358540.2
ENST00000396171.4 ENST00000396167.2 |
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
| chr1_+_33352036 | 2.25 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
| chr17_+_43971643 | 2.25 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
| chr12_+_77158021 | 2.24 |
ENST00000550876.1
|
ZDHHC17
|
zinc finger, DHHC-type containing 17 |
| chr10_+_95517566 | 2.24 |
ENST00000542308.1
|
LGI1
|
leucine-rich, glioma inactivated 1 |
| chr16_+_3019552 | 2.24 |
ENST00000572687.1
|
PAQR4
|
progestin and adipoQ receptor family member IV |
| chr11_-_18813110 | 2.24 |
ENST00000396168.1
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
| chr5_+_169931009 | 2.23 |
ENST00000328939.4
ENST00000390656.4 |
KCNIP1
|
Kv channel interacting protein 1 |
| chr19_-_47164386 | 2.22 |
ENST00000391916.2
ENST00000410105.2 |
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
| chr7_+_24323782 | 2.21 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
| chr16_-_49891694 | 2.21 |
ENST00000562520.1
|
ZNF423
|
zinc finger protein 423 |
| chr13_+_21277482 | 2.21 |
ENST00000304920.3
|
IL17D
|
interleukin 17D |
| chr5_+_71014990 | 2.21 |
ENST00000296777.4
|
CARTPT
|
CART prepropeptide |
| chr8_+_26435359 | 2.20 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr22_-_44258280 | 2.19 |
ENST00000540422.1
|
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr13_-_95364389 | 2.19 |
ENST00000376945.2
|
SOX21
|
SRY (sex determining region Y)-box 21 |
| chr10_-_98945677 | 2.18 |
ENST00000266058.4
ENST00000371041.3 |
SLIT1
|
slit homolog 1 (Drosophila) |
| chrX_+_37545012 | 2.17 |
ENST00000378616.3
|
XK
|
X-linked Kx blood group (McLeod syndrome) |
| chr2_-_97652290 | 2.17 |
ENST00000327896.3
|
FAM178B
|
family with sequence similarity 178, member B |
| chr11_+_1411503 | 2.17 |
ENST00000526678.1
|
BRSK2
|
BR serine/threonine kinase 2 |
| chr15_+_29131103 | 2.17 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
| chr5_-_83680192 | 2.16 |
ENST00000380138.3
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3 |
| chr10_+_105315102 | 2.16 |
ENST00000369777.2
|
NEURL
|
neuralized E3 ubiquitin protein ligase 1 |
| chr17_+_40834580 | 2.16 |
ENST00000264638.4
|
CNTNAP1
|
contactin associated protein 1 |
| chr6_+_73331520 | 2.16 |
ENST00000342056.2
ENST00000355194.4 |
KCNQ5
|
potassium voltage-gated channel, KQT-like subfamily, member 5 |
| chr10_+_105253661 | 2.15 |
ENST00000369780.4
|
NEURL
|
neuralized E3 ubiquitin protein ligase 1 |
| chrX_-_132091284 | 2.15 |
ENST00000370833.2
|
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2 |
| chr3_-_184870751 | 2.15 |
ENST00000335012.2
|
C3orf70
|
chromosome 3 open reading frame 70 |
| chr10_+_48355024 | 2.14 |
ENST00000395702.2
ENST00000442001.1 ENST00000433077.1 ENST00000436850.1 ENST00000494156.1 ENST00000586537.1 |
ZNF488
|
zinc finger protein 488 |
| chr5_-_176056974 | 2.14 |
ENST00000510387.1
ENST00000506696.1 |
SNCB
|
synuclein, beta |
| chr1_-_228603694 | 2.13 |
ENST00000366697.2
|
TRIM17
|
tripartite motif containing 17 |
| chr4_-_5894777 | 2.13 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
| chr2_-_170219079 | 2.12 |
ENST00000263816.3
|
LRP2
|
low density lipoprotein receptor-related protein 2 |
| chr13_-_84456527 | 2.12 |
ENST00000377084.2
|
SLITRK1
|
SLIT and NTRK-like family, member 1 |
| chr1_-_111150048 | 2.11 |
ENST00000485317.1
|
KCNA2
|
potassium voltage-gated channel, shaker-related subfamily, member 2 |
| chr22_-_38851205 | 2.11 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
| chr6_-_40555176 | 2.11 |
ENST00000338305.6
|
LRFN2
|
leucine rich repeat and fibronectin type III domain containing 2 |
| chr19_-_44124019 | 2.10 |
ENST00000300811.3
|
ZNF428
|
zinc finger protein 428 |
| chr16_+_330448 | 2.09 |
ENST00000447871.1
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
| chr11_-_35440579 | 2.08 |
ENST00000606205.1
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
| chr20_-_41818536 | 2.08 |
ENST00000373193.3
ENST00000373198.4 ENST00000373201.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
| chr11_+_1411129 | 2.07 |
ENST00000308219.9
ENST00000528841.1 ENST00000531197.1 ENST00000308230.5 |
BRSK2
|
BR serine/threonine kinase 2 |
| chr6_-_105584560 | 2.07 |
ENST00000336775.5
|
BVES
|
blood vessel epicardial substance |
| chr19_-_38747172 | 2.06 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| chr10_+_26505179 | 2.06 |
ENST00000376261.3
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
| chr11_+_65601112 | 2.05 |
ENST00000308342.6
|
SNX32
|
sorting nexin 32 |
| chr18_-_70210764 | 2.03 |
ENST00000585159.1
ENST00000584764.1 |
CBLN2
|
cerebellin 2 precursor |
| chr19_-_2721336 | 2.03 |
ENST00000588128.1
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
| chr8_+_54793425 | 2.02 |
ENST00000522225.1
|
RGS20
|
regulator of G-protein signaling 20 |
| chr16_-_70713928 | 2.02 |
ENST00000576338.1
|
MTSS1L
|
metastasis suppressor 1-like |
| chr5_-_73937244 | 2.01 |
ENST00000302351.4
ENST00000510316.1 ENST00000508331.1 |
ENC1
|
ectodermal-neural cortex 1 (with BTB domain) |
| chr19_-_38746979 | 1.99 |
ENST00000591291.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| chr4_-_6565315 | 1.98 |
ENST00000506140.1
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr1_-_75139397 | 1.98 |
ENST00000326665.5
|
C1orf173
|
chromosome 1 open reading frame 173 |
| chr13_+_51796497 | 1.97 |
ENST00000322475.8
ENST00000280057.6 |
FAM124A
|
family with sequence similarity 124A |
| chr17_+_40118759 | 1.95 |
ENST00000393892.3
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
Network of associatons between targets according to the STRING database.
First level regulatory network of AHR_ARNT2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.7 | 17.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 2.1 | 6.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.9 | 5.6 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 1.8 | 9.1 | GO:0021586 | pons maturation(GO:0021586) |
| 1.7 | 5.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 1.6 | 38.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.6 | 4.7 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 1.5 | 10.7 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 1.5 | 7.5 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 1.4 | 4.2 | GO:0033058 | directional locomotion(GO:0033058) |
| 1.4 | 4.2 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 1.3 | 8.9 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 1.2 | 14.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 1.1 | 2.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 1.1 | 3.3 | GO:0031106 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 1.1 | 3.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 1.0 | 3.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.0 | 3.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 1.0 | 6.2 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.9 | 5.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.9 | 5.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.9 | 2.6 | GO:0014044 | Schwann cell development(GO:0014044) |
| 0.8 | 5.0 | GO:0021764 | amygdala development(GO:0021764) |
| 0.7 | 3.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.7 | 3.6 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.7 | 2.1 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.7 | 9.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.7 | 13.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.6 | 1.9 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.6 | 1.8 | GO:0070446 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.6 | 1.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.6 | 2.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.6 | 1.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.6 | 1.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.6 | 1.7 | GO:2000374 | cadmium ion homeostasis(GO:0055073) negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
| 0.6 | 10.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.6 | 1.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.6 | 1.7 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.5 | 3.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.5 | 1.6 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.5 | 3.2 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.5 | 1.1 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.5 | 1.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.5 | 5.2 | GO:0015820 | leucine transport(GO:0015820) |
| 0.5 | 1.5 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.5 | 3.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 | 11.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.5 | 2.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.5 | 2.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.5 | 2.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.5 | 1.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.5 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.5 | 14.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 | 8.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.5 | 5.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.4 | 1.3 | GO:0021894 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.4 | 1.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.4 | 1.7 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.4 | 3.0 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.4 | 4.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.4 | 5.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.4 | 0.4 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.4 | 2.1 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 0.4 | 1.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.4 | 5.8 | GO:0003360 | brainstem development(GO:0003360) |
| 0.4 | 1.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.4 | 2.0 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.4 | 1.2 | GO:0051795 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) uterine wall breakdown(GO:0042704) positive regulation of catagen(GO:0051795) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.4 | 1.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.4 | 2.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 4.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.4 | 3.7 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.4 | 3.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.4 | 1.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.4 | 0.4 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.4 | 1.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.4 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.4 | 3.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 2.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.3 | 1.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 | 1.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 1.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 | 2.3 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.3 | 3.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.3 | 4.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.3 | 1.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.3 | 11.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 | 2.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 | 15.8 | GO:0007616 | long-term memory(GO:0007616) |
| 0.3 | 18.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 | 2.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 | 2.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.3 | 2.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.3 | 1.8 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.3 | 3.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.3 | 2.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.3 | 0.8 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.3 | 2.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.3 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.3 | 0.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.3 | 1.4 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.3 | 1.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.3 | 1.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.3 | 1.6 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.3 | 0.8 | GO:1902309 | regulation of heart rate by hormone(GO:0003064) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 | 1.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 1.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.3 | 3.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 2.0 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.3 | 2.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.2 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.2 | 6.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 7.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 0.7 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 | 0.5 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.2 | 1.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.2 | 4.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.2 | 18.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.2 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 1.2 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 | 0.9 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 0.9 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 4.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 3.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.9 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.2 | 1.3 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.2 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 3.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 | 0.4 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.2 | 0.6 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 | 1.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 0.6 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.2 | 2.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.2 | 0.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 | 1.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 1.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 0.8 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 0.6 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.2 | 2.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.2 | 1.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 0.8 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 0.6 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.2 | 0.8 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 | 7.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.2 | 0.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 0.7 | GO:1990927 | short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.2 | 2.0 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 | 1.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 1.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.2 | 0.7 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
| 0.2 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 1.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 | 0.7 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.2 | 2.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 1.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.2 | 0.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.2 | 0.8 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.2 | 1.8 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.2 | 0.7 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.2 | 2.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.2 | 1.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.2 | 2.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 | 1.3 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 | 1.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.2 | 1.3 | GO:0071105 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.2 | 1.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.2 | 1.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.2 | 1.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 | 2.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 1.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.2 | 0.5 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.2 | 0.9 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.2 | 6.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.3 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 | 1.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 2.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 0.3 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.1 | 0.7 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.1 | 0.3 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 | 1.0 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 | 2.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.1 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 4.0 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 3.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 1.6 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 1.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 4.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.1 | 0.4 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.1 | 0.6 | GO:0035989 | tendon development(GO:0035989) |
| 0.1 | 0.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.4 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 | 2.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 5.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 1.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 | 1.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 2.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.5 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.1 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 0.1 | 1.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.1 | 0.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 | 1.7 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.1 | 1.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 10.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 | 0.3 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.1 | 0.5 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.1 | 0.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 3.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 0.4 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 2.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
| 0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.1 | 1.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
| 0.1 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.1 | 0.5 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.4 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 | 9.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 | 1.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.1 | 0.7 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.9 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 1.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 1.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 1.7 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 0.7 | GO:1990834 | response to odorant(GO:1990834) |
| 0.1 | 4.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 0.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.1 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.1 | 1.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 0.7 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 1.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 0.3 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 1.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.1 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 0.1 | 2.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.6 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.8 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.1 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 0.8 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 5.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 0.3 | GO:0042245 | RNA repair(GO:0042245) |
| 0.1 | 0.6 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 1.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 1.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 0.5 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.1 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 0.1 | 1.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 1.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 5.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 1.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
| 0.1 | 2.6 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 1.0 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 | 0.3 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.1 | 0.4 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
| 0.1 | 0.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 | 1.7 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.9 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 3.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 | 1.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 1.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 | 0.5 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
| 0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 11.9 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.1 | 1.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 1.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 | 0.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.5 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
| 0.1 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.1 | 0.3 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.1 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 | 0.5 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.1 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.1 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.2 | GO:0032470 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) relaxation of skeletal muscle(GO:0090076) |
| 0.1 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.5 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 | 0.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 2.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 1.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.4 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
| 0.1 | 1.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.6 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 | 0.4 | GO:2000671 | cellular response to sorbitol(GO:0072709) regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 13.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.3 | GO:0072166 | visceral serous pericardium development(GO:0061032) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.1 | 0.4 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.1 | GO:0060577 | pulmonary vein morphogenesis(GO:0060577) |
| 0.1 | 0.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
| 0.1 | 0.9 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.4 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 0.6 | GO:1903826 | arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
| 0.1 | 0.3 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 0.1 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 | 1.1 | GO:0046323 | glucose import(GO:0046323) |
| 0.1 | 6.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 1.4 | GO:0006833 | water transport(GO:0006833) |
| 0.1 | 1.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.1 | 1.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 2.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 1.4 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.3 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.1 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.3 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 1.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 20.0 | GO:0097485 | neuron projection guidance(GO:0097485) |
| 0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.1 | 0.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.1 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 3.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 0.4 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
| 0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 1.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 | 1.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 1.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 1.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 | 1.8 | GO:0014075 | response to amine(GO:0014075) |
| 0.1 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.1 | 1.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.1 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.1 | 14.2 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.1 | 1.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.3 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 0.2 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.1 | 0.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 | 1.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.1 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 1.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.9 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 | 0.3 | GO:0015853 | adenine transport(GO:0015853) |
| 0.1 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 8.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.1 | 0.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 2.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 1.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.6 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 0.3 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 2.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 | 0.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 | 5.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.0 | 0.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.0 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.0 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.0 | 0.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.0 | 0.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 | 0.2 | GO:0035822 | gene conversion(GO:0035822) |
| 0.0 | 0.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.0 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.3 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.0 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
| 0.0 | 0.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.1 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.0 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 | 0.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 | 0.4 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.0 | 0.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.0 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.0 | 0.2 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 | 0.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.4 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.0 | 0.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.0 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 | 0.2 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 0.3 | GO:0003014 | renal system process(GO:0003014) |
| 0.0 | 0.1 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.0 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 | 0.4 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 | 1.1 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.0 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.0 | 0.5 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.1 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.0 | 0.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 1.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.0 | 0.1 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 | 0.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.0 | 1.5 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.0 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 | 0.1 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.0 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.4 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.1 | GO:2000410 | tolerance induction dependent upon immune response(GO:0002461) regulation of thymocyte migration(GO:2000410) |
| 0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.0 | 0.4 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 | 1.1 | GO:0008306 | associative learning(GO:0008306) |
| 0.0 | 0.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 | 0.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.6 | GO:0031577 | spindle checkpoint(GO:0031577) |
| 0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.0 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 4.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 | 0.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
| 0.0 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.0 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.1 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.2 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.0 | 1.2 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.3 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.0 | 0.2 | GO:0007129 | synapsis(GO:0007129) |
| 0.0 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 | 0.4 | GO:0060004 | reflex(GO:0060004) |
| 0.0 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 | 0.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.0 | 0.6 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.0 | 0.5 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 | 0.1 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 0.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.0 | 0.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 | 0.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 1.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) |
| 0.0 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.5 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.0 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.5 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.0 | 0.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
| 0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.0 | 0.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.1 | GO:1902460 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 | 0.1 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.4 | GO:0060323 | head morphogenesis(GO:0060323) |
| 0.0 | 0.5 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
| 0.0 | 0.9 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.7 | GO:0098840 | protein transport along microtubule(GO:0098840) |
| 0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 | 0.7 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.0 | 0.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.0 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
| 0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 | 0.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.0 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 0.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
| 0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
| 0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.0 | 0.0 | GO:0048073 | regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
| 0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.0 | GO:0007067 | mitotic nuclear division(GO:0007067) |
| 0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.2 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.0 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.0 | 0.0 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.0 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.0 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.0 | 0.0 | GO:0071262 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.0 | 0.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 | 0.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 0.0 | 0.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 | 0.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 0.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.0 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 0.0 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 | 0.4 | GO:0007099 | centriole replication(GO:0007099) |
| 0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.0 | 0.2 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 0.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.0 | 0.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.0 | GO:0070781 | response to biotin(GO:0070781) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 13.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 1.8 | 16.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 1.3 | 5.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.3 | 6.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.8 | 5.6 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.8 | 3.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.7 | 10.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.7 | 2.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.6 | 3.2 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.6 | 3.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.6 | 4.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.6 | 5.0 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.6 | 21.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.5 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.5 | 1.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.5 | 8.4 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.5 | 5.0 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.4 | 6.7 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.4 | 1.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.4 | 3.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 1.1 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.4 | 1.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.3 | 0.7 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.3 | 1.3 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.3 | 2.5 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.3 | 3.0 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 2.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.3 | 2.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 1.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.3 | 11.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 3.7 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.3 | 1.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.2 | 4.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 1.4 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.2 | 5.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 0.2 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.2 | 3.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 33.9 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 2.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
| 0.2 | 1.4 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 0.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.2 | 0.7 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.2 | 1.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 1.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.2 | 0.9 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.2 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.2 | 1.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.2 | 3.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.2 | 1.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 0.9 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.2 | 1.7 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 10.9 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 3.9 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 7.0 | GO:0043679 | axon terminus(GO:0043679) |
| 0.1 | 6.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 2.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.1 | 17.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 2.4 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 0.5 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.1 | 0.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.1 | 15.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 2.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 12.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 3.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.7 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.1 | 3.8 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.6 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 1.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 1.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 39.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 20.9 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
| 0.1 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.6 | GO:0031673 | H zone(GO:0031673) |
| 0.1 | 3.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 15.6 | GO:0098793 | presynapse(GO:0098793) |
| 0.1 | 54.5 | GO:0045202 | synapse(GO:0045202) |
| 0.1 | 0.5 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.3 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 0.8 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 0.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 2.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
| 0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 1.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.1 | 2.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 3.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.1 | 15.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 1.8 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.1 | 2.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 6.4 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 0.8 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 0.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.1 | 0.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 18.0 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 5.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.1 | 0.2 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 1.5 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.0 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.0 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.0 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.0 | 1.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.0 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
| 0.0 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.0 | 1.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 2.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 22.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.0 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 1.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 2.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 3.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 7.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.0 | 20.0 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 1.0 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.0 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
| 0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.1 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.0 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.0 | 1.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.0 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.9 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.0 | 0.4 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
| 0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.0 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.0 | 0.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 1.2 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 13.4 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 1.6 | 14.5 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 1.6 | 4.7 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 1.4 | 11.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 1.4 | 12.2 | GO:0042835 | BRE binding(GO:0042835) |
| 1.3 | 5.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.3 | 5.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 1.3 | 38.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 1.2 | 6.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 1.2 | 17.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 1.1 | 3.2 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 1.0 | 3.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.0 | 3.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.9 | 6.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.8 | 15.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.8 | 3.0 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.7 | 5.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.7 | 3.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.7 | 4.4 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.7 | 2.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.6 | 4.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.6 | 1.8 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.6 | 8.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.6 | 2.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.6 | 2.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.6 | 1.7 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.6 | 1.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.6 | 7.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.5 | 5.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.5 | 17.4 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.5 | 5.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.5 | 5.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.5 | 1.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.4 | 2.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.4 | 4.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.4 | 11.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.4 | 1.7 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.4 | 1.3 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
| 0.4 | 25.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.4 | 2.5 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.4 | 4.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 2.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.4 | 2.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 1.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.4 | 6.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.3 | 2.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.3 | 1.7 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.3 | 1.3 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.3 | 0.3 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.3 | 3.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 1.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.3 | 2.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 7.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.3 | 1.4 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.3 | 0.8 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.3 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.3 | 2.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.3 | 1.9 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.3 | 1.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.3 | 1.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.3 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.3 | 1.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.3 | 1.0 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.3 | 1.0 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.3 | 1.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.3 | 1.8 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.2 | 0.7 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.2 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 4.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 1.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.2 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.2 | 2.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 4.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.2 | 0.9 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.2 | 2.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.2 | 0.2 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.2 | 1.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.2 | 0.6 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.2 | 0.6 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.2 | 10.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 1.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.2 | 0.6 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.2 | 1.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.2 | 1.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.2 | 4.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 7.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.2 | 1.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.2 | 0.8 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 0.8 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.2 | 1.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 1.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.2 | 0.6 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 1.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.2 | 1.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 1.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.2 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 1.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.2 | 0.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 1.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 1.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.2 | 0.5 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 3.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
| 0.2 | 5.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 3.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 5.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.2 | 2.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 3.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 1.5 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.2 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.2 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 0.6 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 1.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.2 | 1.1 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.2 | 0.5 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.2 | 17.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.2 | 0.9 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.2 | 1.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.2 | 1.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.1 | 4.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.1 | 2.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.1 | 0.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
| 0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.1 | 0.6 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 1.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.4 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 0.4 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 1.9 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.1 | 2.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.4 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.1 | 5.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 0.5 | GO:0070026 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) nitrite reductase activity(GO:0098809) |
| 0.1 | 2.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.5 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.1 | 1.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 1.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.1 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.6 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 0.4 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.1 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 0.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 0.8 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 4.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 3.6 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 3.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.5 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 3.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 1.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 1.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 4.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 4.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.6 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.1 | 3.4 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.1 | 1.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.1 | 0.8 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.1 | 0.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.1 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.1 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.1 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.3 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.1 | 0.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.1 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.3 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 3.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 2.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.1 | 0.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 8.6 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 4.1 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 5.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.1 | 1.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 6.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.1 | 1.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 1.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.1 | 2.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 44.3 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 2.2 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 2.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 0.4 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
| 0.1 | 0.4 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 0.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.1 | 0.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.1 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 9.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.1 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 1.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
| 0.1 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.1 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.2 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 0.5 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 1.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.2 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 0.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 2.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 4.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 3.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 11.3 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 4.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 0.2 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.1 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.0 | 1.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.0 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.0 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.1 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) guanylyltransferase activity(GO:0070568) |
| 0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.0 | 0.3 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.0 | 1.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.0 | 0.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.0 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.0 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.0 | 16.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.0 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.0 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 1.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.0 | 1.0 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0070546 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.0 | 0.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 12.2 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.4 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 1.9 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
| 0.0 | 0.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.0 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 3.0 | GO:0003774 | motor activity(GO:0003774) |
| 0.0 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.0 | 1.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.0 | 0.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.0 | 0.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.0 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 2.7 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
| 0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.0 | 0.1 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.0 | 0.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.0 | 0.1 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.0 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 0.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.0 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.1 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.0 | 0.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.0 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
| 0.0 | 9.0 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.0 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 23.8 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 1.0 | GO:0043236 | laminin binding(GO:0043236) |
| 0.0 | 0.6 | GO:0042277 | peptide binding(GO:0042277) |
| 0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
| 0.0 | 0.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.0 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.0 | 8.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 0.2 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
| 0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.0 | 0.0 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.0 | 0.4 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 0.0 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.0 | 1.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.0 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.0 | 0.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.0 | 0.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 37.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.4 | 9.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 1.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.3 | 12.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 6.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 11.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 7.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 4.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 9.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 5.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 4.4 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 5.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 10.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 1.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 5.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 3.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 5.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 1.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 1.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 2.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 1.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 3.8 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 2.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.0 | 2.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 6.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 35.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.8 | 18.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.8 | 7.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.6 | 13.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.5 | 18.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.5 | 12.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.4 | 8.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.4 | 25.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.4 | 14.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 6.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.3 | 9.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 3.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 15.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 4.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.2 | 8.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 1.6 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.2 | 2.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 0.6 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.1 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 5.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 5.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 5.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 2.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 1.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 5.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 1.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 1.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 3.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 4.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 2.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 0.1 | 3.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 3.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 2.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 2.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 5.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.1 | 1.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.0 | 1.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 10.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 1.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 3.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 1.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 0.9 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
| 0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 2.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 0.9 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.0 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 1.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |